GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a substantial shift in how we approach diabetes mellitus . These injectable drugs function to mimicking the body’s inherent GLP-1 substance , https://prbookmarkingwebsites.com/story29192417/glp-1-a-significant-breakthrough-in-blood-sugar-management